Therapies for breast cancer, multiple myeloma, and HIV ranked the highest across audit of commercial performance, therapeutic value, and R&D complexity.
WALTHAM, Mass. – December 17, 2018 — Trinity, a leading global life science consulting firm, today announced the findings of its third annual Trinity Drug Index which assessed 57 novel drugs approved by the FDA in 2015. The index ranks drug performance against three categories: commercial performance, therapeutic value and R&D complexity, assigning each drug a score in those…
Read Now
Leading global life sciences consulting firm Trinity has been named to Consulting Magazine’s 2018 lists of “Best Small Firms to Work For” as well as the magazine’s list of “Fastest Growing Firms” for the third consecutive year.
Consulting Magazine’s annual ranking of the industry’s “Best Firms to Work For” is based on employee survey responses regarding six areas of employee satisfaction including culture, career development, work/life balance, client engagement, compensation and benefits, and firm leadership. Consulting Magazine’s list of “Fastest…
Read Now
Experts from Trinity have published a bylined article in In Vivo. The article, titled, “You May Be Making These Drug Forecasting Mistakes,” breaks down the most common missteps in forecasting and highlights how to design and use the best models for the most accurate outcomes. In the article, Alex Chiang, Principal, and Adrian Watson, Senior Manager, Modeling and Analytics, discuss the top 10 most common drug forecasting errors, which fall into three broad categories: model design issues, model maintenance issues,…
Read Now
Waltham, MA—Global life sciences consulting firm Trinity today announced it will present the panel discussion, “Tissue-Agnostic Cancer Drug Development: An Emerging Paradigm Shift?” along with Pfizer and the Healthcare Businesswomen’s Association (HBA). The event, featuring perspectives from clinical, commercial, regulatory and market access experts, will take place at Pfizer’s headquarters in New York City on October 23, 2018 from 5:30-8 pm.
Cancer treatment has made significant strides toward the promise of personalized medicine in recent years. With Keytruda’s tissue-agnostic MSI-H/dMMR…
Read Now
Trinity issued a paper on asset valuation that explores the common methodologies for the valuation of pharma and biotech assets and highlights key considerations for capturing asset-specific nuances and accurately reflecting value.…
Read Now
Click here to visit TGaS.com
Next milestone in Trinity’s build, buy and partner growth strategy further accelerates the firm’s mission and vision to lead transformation in the life sciences industry
Waltham, MA—Global life sciences consulting firm Trinity today announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. The acquisition marks another proof point in Trinity’s overarching growth strategy and builds upon previous successes and momentum including a strengthened…
Read Now
Boston, August 20, 2018 – Leading global life sciences consulting firm Trinity today announced that it has welcomed new Principal, Christian Frois, PhD, to the firm as well as seven other individuals to its leadership team. Trinity also welcomes new full-time hires, totaling 40 new employees company-wide this year to date.
Frois specializes in the development and evaluation of innovative commercial and evidence strategies for biopharmaceutical and medical device companies, and is a recognized expert on pricing, contracting and market…
Read Now
Trinity’s Breanna Liponis and Alyssa Blaize recently attended Battle Summit to hear firsthand from Memorial Sloan Kettering doctors and researchers how Cycle for Survival funding is helping rare cancer patients everywhere. The team heard about important studies, initiatives and clinical trials funded through Cycle for Survival donors and participants for salivary gland cancer, pancreatic neuroendocrine tumors and advanced melanoma, among other areas. In addition, the team heard the latest updates on Loxo Oncology’s TRK fusion inhibitor, larotrectinib, developed with Cycle…
Read Now
Leading global life sciences consulting firm Trinity today announced that it has been named to the Forbes America’s Best Management Consulting Firms 2018 list. Trinity has been named among the best management consulting firms every year since the inaugural ranking in 2016.
The list, developed by Forbes in partnership with Statista, considers more than 1,300 consulting firms and surveys more than 1,000 senior executives to determine the best management consulting firms based on recent performance and first-hand experience. The list…
Read Now
Leading global life sciences consulting firm Trinity today released a new whitepaper analyzing the oncology clinical trial pipeline to determine the extent to which basket trials are being utilized and, in particular, how many are likely to be registrational studies resulting in tissue-agnostic indications.
Historically, basket trials have been used to explore multiple tumor types in one trial in order to prioritize the ones with the greatest response for further research. However, with Keytruda’s MSI-H and dMMR approval, basket trials…
Read Now
